CN103463561A - Traditional Chinese medicine composition for treating cerebral thrombosis sequelae - Google Patents
Traditional Chinese medicine composition for treating cerebral thrombosis sequelae Download PDFInfo
- Publication number
- CN103463561A CN103463561A CN2013103737091A CN201310373709A CN103463561A CN 103463561 A CN103463561 A CN 103463561A CN 2013103737091 A CN2013103737091 A CN 2013103737091A CN 201310373709 A CN201310373709 A CN 201310373709A CN 103463561 A CN103463561 A CN 103463561A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 206010008132 Cerebral thrombosis Diseases 0.000 title abstract description 9
- 201000001429 Intracranial Thrombosis Diseases 0.000 title abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 206010008118 cerebral infarction Diseases 0.000 claims description 18
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 17
- 241000903946 Clematidis Species 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 10
- 241000237636 Pheretima Species 0.000 claims description 10
- 241000222640 Polyporus Species 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 241000241550 Cyathula Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 37
- 239000008280 blood Substances 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- ZIUSSTSXXLLKKK-KOBPDPAPSA-N (1e,4z,6e)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 ZIUSSTSXXLLKKK-KOBPDPAPSA-N 0.000 abstract 1
- 241000748223 Alisma Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N Curcumin Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010019468 Hemiplegia Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127090 anticoagulant agent Drugs 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960000103 thrombolytic agent Drugs 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019452 Hemianopia Diseases 0.000 description 1
- 208000007460 Hemianopsia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000002579 Wernicke Aphasia Diseases 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 238000002585 cerebral angiography Methods 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating cerebral thrombosis sequelae, which comprises the following traditional Chinese medicine raw materials in parts by weight: 10-40 parts of hoantchy root, 10-30 parts of angelica, 10-40 parts of radix codonopsitis, 10-40 parts of suberect spatholobus stem, 10-40 parts of rhizome atractylodis, 5-25 parts of alisma, 5-20 parts of radix cyathulae, 5-20 parts of grifola, 10-40 parts of salvia miltiorrhiza, 10-30 parts of szechuan lovage rhizome, 5-20 parts of peach kernel, 5-20 parts of safflower, 5-20 parts of tall gastrodis tuber, 5-25 parts of cassia twig, 10-30 parts of loranthus parasiticus, 10-40 parts of white paeony root, 2-10 parts of asarum, 5-20 parts of turmeric yellow, 5-20 parts of clematis root, 5-20 parts of lycopodium clavatum, 5-20 parts of lumbricus and 5-15 parts of liquorice. The traditional Chinese medicine composition provided by the invention achieves the efficacies of tonifying liver and kidney, strengthening spleen, tonifying lung, clearing and activating channels and collaterals, promoting blood circulation and removing blood stasis, and has a remarkable cure effect and a reliable action on treatment of cerebral thrombosis sequelae. The medicinal herbs resources of the compositions of the traditional Chinese medicine composition are abundant, the preparation is simple and convenient, the medicine property is mild and toxic and side effects are avoided.
Description
Technical field
The present invention relates to a kind of not pharmaceutical product of definite structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of cerebral infarction sequela.
Background technology
Cerebral thrombosis claims again ischemia apoplexy.Cerebral thrombosis is on cerebral atherosclerosis and speckle basis, under slow blood flow, condition that blood pressure is on the low side, the inner membrance that the visible component of blood is attached to tremulous pulse forms thrombosis, multiple be born in 50 years old after, with advancing age, thickening, hardening in various degree occurs in arteries, loses normal elasticity, and when serious, arterial wall also can occur atherosis.After arteriosclerosis occurs, tunica intima is coarse, tube chamber narrows down, and can form thrombosis, blocks normal blood circulation and tissue ischemia occurs, and after cerebral vessels is blocked, forms cerebral thrombosis.After cerebral thrombosis, the lighter shows as that a side limb activity is dumb, insensitive, error clinically, and severe patient can occur that stupor, gatism are even dead.Different its clinical symptoms in the position that cerebral thrombosis occurs are also different, as occur in cerebral hemisphere, can occur that clinically " three inclined to one side diseases " is hemiplegia, hemianopsia, biased sensory disturbance, or aphasia and Mental Subnormality.As occur in cerebellum or brain stem, acutely dizzy, vomiting, singultus can occur, drink water and send out choke, pronounce hoarse, walk shakiness, quadriplegia etc.Most of survivor leaves sequela and needs hospitalization or home care treatment.Current clinical treatment drug main will be take cerebral vasodilator, anticoagulant and thrombolytic agent as main, though certain curative effect is arranged, untoward reaction and side effect are obvious, the plasma protein in the blood of easily degrading, and expensive.
Chinese medicine is thought, the blood stasis of blood circulating out of vessels meaning, and blood stasis does not go fresh blood not give birth to.Control and should take nourshing blood and promoting blood circulation, dispelling wind and removing obstruction in the collateral, promoting blood circulation to remove obstruction in the collateral as main.
According to theory of Chinese medical science, for the pathogeny of cerebral infarction sequela, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome in prior art, with cerebral vasodilator, anticoagulant and thrombolytic agent treatment cerebral infarction sequela, exist curative effect to pay no attention to think of the deficiency that side effect is large, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment cerebral infarction sequela that has no side effect, can effectively improve the hemiplegia of limb that cerebral thrombosis causes, numb hand and foot, the symptoms such as aphasis, improve life in patients.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of cerebral infarction sequela, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Radix Astragali 10-40 part, Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-40 part, Caulis Spatholobi 10-40 part, Rhizoma Atractylodis 10-40 part, Rhizoma Alismatis 5-25 part, Radix Cyathulae 5-20 part, Polyporus 5-20 part, Radix Salviae Miltiorrhizae 10-40 part, Rhizoma Chuanxiong 10-30 part, Semen Persicae 5-20 part, Flos Carthami 5-20 part, Rhizoma Gastrodiae 5-20 part, Ramulus Cinnamomi 5-25 part, Herba Taxilli 10-30 part, Radix Paeoniae Alba 10-40 part, Herba Asari 2-10 part, Rhizoma Curcumae Longae 5-20 part, Radix Clematidis 5-20 part, Herba Lycopodii 5-20 part, Pheretima 5-20 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of cerebral infarction sequela is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 30 parts of the Radixs Astragali, 20 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Caulis Spatholobis, 30 parts of Rhizoma Atractylodis, 15 parts of Rhizoma Alismatis, 10 parts of Radix Cyathulaes, 10 parts of Polyporus, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of Rhizoma Chuanxiongs, 10 parts, Semen Persicae, 10 parts, Flos Carthami, 10 parts, Rhizoma Gastrodiae, 15 parts of Ramulus Cinnamomi, 20 parts of Herba Taxillis, 30 parts of the Radix Paeoniae Albas, 5 parts of Herba Asaris, 10 parts, Rhizoma Curcumae Longae, 10 parts of Radix Clematidis, 10 parts of Herba Lycopodiis, 10 parts of Pheretimas, 6 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Radix Astragali has that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating are admittedly de-, wind dispelling is transported malicious effect; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, the effect of loosening bowel to relieve constipation; Radix Codonopsis has the effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Caulis Spatholobi has to enrich blood invigorates blood circulation, relaxes through the effect of dredging collateral; That Rhizoma Atractylodis have is drying damp and strengthening spleen, the effect of expelling wind and cold; Rhizoma Alismatis has promoting diuresis to eliminate damp pathogen, treating stranguria effect expels the heat-evil; Radix Cyathulae has the effect of promoting blood circulation to restore menstrual flow, expelling wind and removing dampness, easing joint movement, inducing diuresis for treating stranguria syndrome; Polyporus has the effect of promoting diuresis to eliminate damp pathogen; Radix Salviae Miltiorrhizae has the effect of promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Rhizoma Chuanxiong has the effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Semen Persicae has the effect of blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Flos Carthami has the effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Rhizoma Gastrodiae has the effect of endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral; Ramulus Cinnamomi has the effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Herba Taxilli has the effect of invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit; The Radix Paeoniae Alba has the effect of nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receipts antiperspirant; Herba Asari has the cold expelling that induces sweat, wind-expelling pain-stopping, warming the lung to resolve fluid-retention, sensible effect; Rhizoma Curcumae Longae has the effect of removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia; Radix Clematidis has the effect of expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, expectorant water, the loose hypochondriac lump; Herba Lycopodii has the effect of expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons to promote blood circulation; Pheretima has the effect of clearing heat for calming endogenous wind, lung-clearing asthma-relieving, inducing diuresis for treating stranguria syndrome, current meridians; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, helps using mutual assistant, plays altogether the effect of liver and kidney tonifying, spleen invigorating lung benefiting, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, and the treatment of cerebral infarction sequela is reached to treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 90%, cure rate 30%.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A kind of Chinese medicine composition for the treatment of cerebral infarction sequela, its raw material of Chinese medicine and weight proportion are: Radix Astragali 30g, Radix Angelicae Sinensis 20g, Radix Codonopsis 30g, Caulis Spatholobi 30g, Rhizoma Atractylodis 30g, Rhizoma Alismatis 15g, Radix Cyathulae 10g, Polyporus 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 20g, Semen Persicae 10g, Flos Carthami 10g, Rhizoma Gastrodiae 10g, Ramulus Cinnamomi 15g, Herba Taxilli 20g, Radix Paeoniae Alba 30g, Herba Asari 5g, Rhizoma Curcumae Longae 10g, Radix Clematidis 10g, Herba Lycopodii 10g, Pheretima 10g, Radix Glycyrrhizae 6g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of cerebral infarction sequela, its raw material of Chinese medicine and weight proportion are: Radix Astragali 10g, Radix Angelicae Sinensis 30g, Radix Codonopsis 10g, Caulis Spatholobi 35g, Rhizoma Atractylodis 20g, Rhizoma Alismatis 25g, Radix Cyathulae 5g, Polyporus 15g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 30g, Semen Persicae 5g, Flos Carthami 20g, Rhizoma Gastrodiae 15g, Ramulus Cinnamomi 25g, Herba Taxilli 10g, Radix Paeoniae Alba 40g, Herba Asari 2g, Rhizoma Curcumae Longae 20g, Radix Clematidis 5g, Herba Lycopodii 15g, Pheretima 12g, Radix Glycyrrhizae 5g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of cerebral infarction sequela, its raw material of Chinese medicine and weight proportion are: Radix Astragali 25g, Radix Angelicae Sinensis 15g, Radix Codonopsis 20g, Caulis Spatholobi 40g, Rhizoma Atractylodis 10g, Rhizoma Alismatis 20g, Radix Cyathulae 15g, Polyporus 5g, Radix Salviae Miltiorrhizae 35g, Rhizoma Chuanxiong 15g, Semen Persicae 20g, Flos Carthami 5g, Rhizoma Gastrodiae 12g, Ramulus Cinnamomi 20g, Herba Taxilli 30g, Radix Paeoniae Alba 15g, Herba Asari 4g, Rhizoma Curcumae Longae 12g, Radix Clematidis 20g, Herba Lycopodii 5g, Pheretima 20g, Radix Glycyrrhizae 10g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of cerebral infarction sequela, its raw material of Chinese medicine and weight proportion are: Radix Astragali 40g, Radix Angelicae Sinensis 25g, Radix Codonopsis 35g, Caulis Spatholobi 10g, Rhizoma Atractylodis 40g, Rhizoma Alismatis 5g, Radix Cyathulae 20g, Polyporus 12g, Radix Salviae Miltiorrhizae 25g, Rhizoma Chuanxiong 10g, Semen Persicae 15g, Flos Carthami 12g, Rhizoma Gastrodiae 20g, Ramulus Cinnamomi 5g, Herba Taxilli 25g, Radix Paeoniae Alba 35g, Herba Asari 10g, Rhizoma Curcumae Longae 5g, Radix Clematidis 15g, Herba Lycopodii 12g, Pheretima 15g, Radix Glycyrrhizae 12g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of cerebral infarction sequela, its raw material of Chinese medicine and weight proportion are: Radix Astragali 20g, Radix Angelicae Sinensis 10g, Radix Codonopsis 40g, Caulis Spatholobi 20g, Rhizoma Atractylodis 35g, Rhizoma Alismatis 10g, Radix Cyathulae 12g, Polyporus 20g, Radix Salviae Miltiorrhizae 40g, Rhizoma Chuanxiong 25g, Semen Persicae 12g, Flos Carthami 15g, Rhizoma Gastrodiae 5g, Ramulus Cinnamomi 10g, Herba Taxilli 15g, Radix Paeoniae Alba 10g, Herba Asari 6g, Rhizoma Curcumae Longae 15g, Radix Clematidis 12g, Herba Lycopodii 20g, Pheretima 5g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into to container, add cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct for the first time, adopt intense fire to decoct before at a simmer, boil rear with slow fire boiling 20～30 minutes; Decoct for the second time, add water do not have powder approximately 4 centimetres decocted, the water rear decoction 15～20 minutes of boiling.Decoct extracting juice twice, merge.
A kind of Chinese medicine composition for the treatment of cerebral infarction sequela that the present invention is given with embodiment 1, do clinical efficacy and be summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 50 examples, male 28 examples, female's 22 examples, 50～75 years old age.
Two, diagnosis basis:
1, age of onset is higher, the risk of strokes such as arteriosclerosis and hypertension is arranged or transient ischemic attack was arranged;
2, many static morbidities, occur in sleep or after wakeing up often increasing the weight of symptom gradually.How without severe headache and disturbance of consciousness, hemiplegia, aphasia sign are obvious;
3, how normal cerebrospinal fluid is.The density regions of the visible cerebral ischemia pathological changes of CT scan (6 hours of onset is with interior how normal).Cerebral angiography can show that thrombosis position, degree and side prop up loop condition.Doppler can detect the cerebral blood flow situation, contributes to diagnosis.Carry out hematuria routine, blood glucose, blood fat, blood flow change, electrocardiogram etc. and check, so that discriminatings such as same cerebral hemorrhage, cerebral embolism.
Three, usage and dosage: during clinical practice, potion on the one, the about 400ml of twice extracting juice of decocting, minute morning, late twice empty stomach decoction being taken warmly.It within five days, is a course for the treatment of.Avoid cold and uncooked food during the treatment thing of pungent stimulation.
Four, criterion of therapeutical effect:
1, recovery from illness: lamprophonia, hemiplegia disappear and basic the disappearance, and upper and lower extremities muscular strength functional rehabilitation is normal, takes care of oneself;
2, produce effects: it is unfavorable that language slightly has, and the hemiplegic limb function obviously has certain recovery, can with life is basic, take care of oneself by independent ambulation;
3, effective: language, limb function have certain recovery;
4, invalid: symptom and sign are without alleviating or increasing the weight of.
Five, therapeutic effect: in this clinical observation case, take medicine 6-20 the course for the treatment of, 15 examples of fully recovering, follow up a case by regular visits to and have no recurrence; Produce effects 20 examples, effective 10 examples, invalid 5 examples.Toxic and side effects does not occur during treatment.
Six, model case:
Case 1:
Yao, man, 58 years old.When medical, family members tell its left side facial hemiparalysis generation, dysphonia, and the right side limb activity is limited, through CT examination, is diagnosed as: cerebral infarction sequela.Many hospitalize poor effect once.Take 5 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, it is unfavorable that language slightly has, and limb function obviously recovers; Continue to take 5 courses for the treatment of, lamprophonia, limb functional recover is normal, takes care of oneself.
Case 2:
Bring up certain, female, 65 years old.Burst is spat out white foams, and the right side upper and lower extremities loses movable function, companion's facial hemiparalysis.To leaving hospital after certain hospital is failed to respond to any medical treatment in 15 days, go home afterwards.When medical, check blood pressure 140-70, left side upper and lower extremities afunction, facial hemiparalysis.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, the energy out-of-bed activity, but skelasthenia is not steady on one's legs; Continue to take 4 courses for the treatment of, all diseases disappear, recovery from illness.
Claims (2)
1. a Chinese medicine composition for the treatment of cerebral infarction sequela, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Radix Astragali 10-40 part, Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-40 part, Caulis Spatholobi 10-40 part, Rhizoma Atractylodis 10-40 part, Rhizoma Alismatis 5-25 part, Radix Cyathulae 5-20 part, Polyporus 5-20 part, Radix Salviae Miltiorrhizae 10-40 part, Rhizoma Chuanxiong 10-30 part, Semen Persicae 5-20 part, Flos Carthami 5-20 part, Rhizoma Gastrodiae 5-20 part, Ramulus Cinnamomi 5-25 part, Herba Taxilli 10-30 part, Radix Paeoniae Alba 10-40 part, Herba Asari 2-10 part, Rhizoma Curcumae Longae 5-20 part, Radix Clematidis 5-20 part, Herba Lycopodii 5-20 part, Pheretima 5-20 part, Radix Glycyrrhizae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of cerebral infarction sequela according to claim 1, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 30 parts of the Radixs Astragali, 20 parts of Radix Angelicae Sinensis, 30 parts of Radix Codonopsis, 30 parts of Caulis Spatholobis, 30 parts of Rhizoma Atractylodis, 15 parts of Rhizoma Alismatis, 10 parts of Radix Cyathulaes, 10 parts of Polyporus, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of Rhizoma Chuanxiongs, 10 parts, Semen Persicae, 10 parts, Flos Carthami, 10 parts, Rhizoma Gastrodiae, 15 parts of Ramulus Cinnamomi, 20 parts of Herba Taxillis, 30 parts of the Radix Paeoniae Albas, 5 parts of Herba Asaris, 10 parts, Rhizoma Curcumae Longae, 10 parts of Radix Clematidis, 10 parts of Herba Lycopodiis, 10 parts of Pheretimas, 6 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310373709.1A CN103463561B (en) | 2013-08-26 | 2013-08-26 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310373709.1A CN103463561B (en) | 2013-08-26 | 2013-08-26 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103463561A true CN103463561A (en) | 2013-12-25 |
| CN103463561B CN103463561B (en) | 2015-07-22 |
Family
ID=49788753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310373709.1A Expired - Fee Related CN103463561B (en) | 2013-08-26 | 2013-08-26 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103463561B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893667A (en) * | 2014-04-18 | 2014-07-02 | 河北联合大学 | Traditional Chinese medicine for treating subacute spinal joint degenerative diseases and preparation of compound dropping pill |
| CN104398960A (en) * | 2014-11-18 | 2015-03-11 | 潘海英 | Traditional Chinese medicine preparation for treating sequela of cerebral hemorrhage |
| CN104645189A (en) * | 2015-03-05 | 2015-05-27 | 于巧媛 | Traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis |
| CN105477519A (en) * | 2015-12-22 | 2016-04-13 | 王凯 | Rheumatism arthralgia treating traditional Chinese medicine |
| CN108324859A (en) * | 2018-03-31 | 2018-07-27 | 丁永奎 | A kind of Chinese medicine composition for treating apoplexy sequelae |
| CN110755527A (en) * | 2019-12-20 | 2020-02-07 | 吕峰展 | Medicine for treating early-stage kidney-yang deficiency stroke hemiplegia and preparation method thereof |
| CN111759989A (en) * | 2020-07-16 | 2020-10-13 | 中山大学附属第一医院 | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086430A (en) * | 1993-05-27 | 1994-05-11 | 高齐崧 | The compound method of the health that collapses from physical exhaustion |
| CN1185961A (en) * | 1996-12-26 | 1998-07-01 | 郭贵江 | Capsule for apoplexy |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1336225A (en) * | 2001-08-21 | 2002-02-20 | 徐凤玉 | Cerebral thrombus treating traditional Chinese medicine |
| CN1739742A (en) * | 2005-09-05 | 2006-03-01 | 胡仕敏 | Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process |
| CN101002899A (en) * | 2007-01-11 | 2007-07-25 | 许新华 | Pure traditional Chinese medicine preparation for treating hemiparalysis |
-
2013
- 2013-08-26 CN CN201310373709.1A patent/CN103463561B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086430A (en) * | 1993-05-27 | 1994-05-11 | 高齐崧 | The compound method of the health that collapses from physical exhaustion |
| CN1185961A (en) * | 1996-12-26 | 1998-07-01 | 郭贵江 | Capsule for apoplexy |
| CN1336225A (en) * | 2001-08-21 | 2002-02-20 | 徐凤玉 | Cerebral thrombus treating traditional Chinese medicine |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1739742A (en) * | 2005-09-05 | 2006-03-01 | 胡仕敏 | Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process |
| CN101002899A (en) * | 2007-01-11 | 2007-07-25 | 许新华 | Pure traditional Chinese medicine preparation for treating hemiparalysis |
Non-Patent Citations (1)
| Title |
|---|
| 司玫等: "补阳还五汤的临床新用途", 《时珍国医国药》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893667A (en) * | 2014-04-18 | 2014-07-02 | 河北联合大学 | Traditional Chinese medicine for treating subacute spinal joint degenerative diseases and preparation of compound dropping pill |
| CN104398960A (en) * | 2014-11-18 | 2015-03-11 | 潘海英 | Traditional Chinese medicine preparation for treating sequela of cerebral hemorrhage |
| CN104645189A (en) * | 2015-03-05 | 2015-05-27 | 于巧媛 | Traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis |
| CN105477519A (en) * | 2015-12-22 | 2016-04-13 | 王凯 | Rheumatism arthralgia treating traditional Chinese medicine |
| CN108324859A (en) * | 2018-03-31 | 2018-07-27 | 丁永奎 | A kind of Chinese medicine composition for treating apoplexy sequelae |
| CN110755527A (en) * | 2019-12-20 | 2020-02-07 | 吕峰展 | Medicine for treating early-stage kidney-yang deficiency stroke hemiplegia and preparation method thereof |
| CN111759989A (en) * | 2020-07-16 | 2020-10-13 | 中山大学附属第一医院 | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103463561B (en) | 2015-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1315526C (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN103463561B (en) | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae | |
| CN103463349B (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN103316204B (en) | One treats hypertensive Chinese medicine composition | |
| CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
| CN103536777B (en) | Traditional Chinese medicinal composition for treating knee osteoarthritis | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103386089B (en) | Chinese medicine composition for treating liver-stomach disharmony | |
| CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN103860812A (en) | Chinese medicine composition for treating deficiency of kidney-yang | |
| CN103223139A (en) | Traditional Chinese medicinal composition for treating chronic ulcerative colitis | |
| CN105106909A (en) | Traditional Chinese medicine composition for treating hepatitis A | |
| CN104645223A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN103816470A (en) | Traditional Chinese medicine composition for treating anorexia | |
| CN103536856B (en) | A kind of Chinese medicine composition for the treatment of lower abdominal pain | |
| CN102784256B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
| CN102512543A (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN104758649A (en) | Traditional Chinese medicine composition for treating numbness of limbs | |
| CN105663612A (en) | Traditional Chinese medicine composition for treating ankylosing spondylitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: HAO KUN Free format text: FORMER OWNER: RONGCHENG RESEARCH INSTITUTE OF SCIENTIFIC + TECHNICAL INFORMATION Effective date: 20150619 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Gao Kun Inventor after: Shi Lu Inventor after: Yu Jinyang Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: HAO KUN SHI LU YU JINYANG SUN SHENGBO |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150619 Address after: 264400 Weihai, Zhejiang Province, Wendeng District, East Hill Road, No. 3 Applicant after: Gao Kun Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Rongcheng Research Institute of Scientific & Technical Information |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150722 Termination date: 20160826 |